PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agent: Feasibility study of a Gd‐micelle contrast agent for MR lymphography
Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Am...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 47; no. 1; pp. 238 - 245 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL).
Materials and Methods
Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T1‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life (T1/2) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints.
Results
The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image (P = 0.006) and in inflamed lymph node of a 360‐minute image (P = 0.009).
Conclusion
Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes.
Level of Evidence: 1
Technical Efficacy: Stage 1
J. Magn. Reson. Imaging 2018;47:238–245. |
---|---|
AbstractList | Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 µmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T1-weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T1/2) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009). Conclusion Compared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245. PURPOSETo investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL).MATERIALS AND METHODSTwenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T1 -weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T1/2 ) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints.RESULTSThe mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009).CONCLUSIONCompared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes.LEVEL OF EVIDENCE1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245. Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T 1 ‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life ( T 1/2 ) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle ( P = 0.004). In addition, the AUC was larger ( P < 0.001) and T 1/2 was longer ( P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image ( P = 0.006) and in inflamed lymph node of a 360‐minute image ( P = 0.009). Conclusion Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238–245. Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic resonance lymphography (MRL). Materials and Methods Twenty‐four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd‐micelle or gadofluorine P in the right rear footpad. Identical 3D T1‐weighted gradient‐echo imaging (1T MRI system) were subsequently obtained to create time–intensity curves of the right popliteal, sacral, and lumbar‐aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half‐life (T1/2) of CR of the popliteal lymph node were assessed by two‐way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. Results The mean peak CR of Gd‐micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd‐micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T1/2 was longer (P < 0.001) for Gd‐micelle. In qualitative assessment, Gd‐micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar‐aortic lymph node of a 360‐minute image (P = 0.006) and in inflamed lymph node of a 360‐minute image (P = 0.009). Conclusion Compared to gadofluorine P, Gd‐micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. Level of Evidence: 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238–245. To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance lymphography (MRL). Twenty-four female BALB/c mice were randomly divided into four groups of six mice each. Among them, mice of two groups were injected of complete Freund's adjuvant to obtain inflamed lymph nodes. We subcutaneously injected 0.5 μmol Gd per mouse of Gd-micelle or gadofluorine P in the right rear footpad. Identical 3D T -weighted gradient-echo imaging (1T MRI system) were subsequently obtained to create time-intensity curves of the right popliteal, sacral, and lumbar-aortic lymph nodes and to measure the contrast ratios (CRs). The peak CR, area under the curve (AUC), and elimination half-life (T ) of CR of the popliteal lymph node were assessed by two-way factorial analysis of variance. We also performed a qualitative assessment of normal and inflamed lymph node at three timepoints. The mean peak CR of Gd-micelle was 2.64 and 1.89 for gadofluorine P in normal mice, and 3.48 and 2.73 in the inflamed lymph node. Statistically, peak CR was higher for Gd-micelle (P = 0.004). In addition, the AUC was larger (P < 0.001) and T was longer (P < 0.001) for Gd-micelle. In qualitative assessment, Gd-micelle demonstrated the same or higher scores in every lymph node, and demonstrated a higher score in lumbar-aortic lymph node of a 360-minute image (P = 0.006) and in inflamed lymph node of a 360-minute image (P = 0.009). Compared to gadofluorine P, Gd-micelle showed higher and more prolonged enhancement in MRL imaging in normal and inflamed lymph nodes. 1 Technical Efficacy: Stage 1 J. Magn. Reson. Imaging 2018;47:238-245. |
Author | Akai, Hiroyuki Ohtomo, Kuni Shiraishi, Kouichi Abe, Osamu Yokoyama, Masayuki Inoue, Yusuke Kiryu, Shigeru Nojima, Masanori Yasaka, Koichiro |
Author_xml | – sequence: 1 givenname: Hiroyuki surname: Akai fullname: Akai, Hiroyuki organization: Institute of Medical Science, University of Tokyo – sequence: 2 givenname: Kouichi surname: Shiraishi fullname: Shiraishi, Kouichi organization: Research Center for Medical Science, Jikei University School of Medicine – sequence: 3 givenname: Masayuki surname: Yokoyama fullname: Yokoyama, Masayuki organization: Research Center for Medical Science, Jikei University School of Medicine – sequence: 4 givenname: Koichiro surname: Yasaka fullname: Yasaka, Koichiro organization: Institute of Medical Science, University of Tokyo – sequence: 5 givenname: Masanori surname: Nojima fullname: Nojima, Masanori organization: Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo – sequence: 6 givenname: Yusuke surname: Inoue fullname: Inoue, Yusuke organization: Kitasato University School of Medicine – sequence: 7 givenname: Osamu surname: Abe fullname: Abe, Osamu organization: Graduate School of Medicine, University of Tokyo – sequence: 8 givenname: Kuni surname: Ohtomo fullname: Ohtomo, Kuni organization: International University of Health and Welfare – sequence: 9 givenname: Shigeru surname: Kiryu fullname: Kiryu, Shigeru email: kiryu-tky@umin.ac.jp organization: Institute of Medical Science, University of Tokyo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28419613$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1L3UAUhgex-L3xB5SBbmwhOp_JjDsRvbVcUUTXw9zkROeSZOJMQsmu-276G_tLOrdXBbvo6rxwnvNw4N1Fm53vAKFDSo4pIexk2QZ3zGQhyAbaoZKxjEmVb6ZMJM-oIsU22o1xSQjRWsgttM2UoDqnfAf9vL2Y_f7xq_fNdDRPoZmi6-BzSgsbocKrRQvBlbh1JTQN4Ou7K1z6bgg2Dtg-Qjec4kuw0S1c44YJx2GsJuxrbPGsSp7Xu_c3uPYhqXCy90_-Mdj-adpHH2rbRDh4mXvo4fLi_vxrNr-ZXZ2fzbNSSE2yBZFgacUUUKWIpVoXtRC1FlrnpVAV6MQprgvOZU4rLgWV3NpaMF4SVed8Dx2tvX3wzyPEwbQurp60HfgxmqTVRaE10Qn99A-69GPo0neG6kIKxTgrEvVlTZXBxxigNn1wrQ2TocSsKjKriszfihL88UU5Llqo3tDXThJA18B318D0H5X5lrpYS_8AJGGhDA |
CitedBy_id | crossref_primary_10_1016_j_jmir_2019_09_006 crossref_primary_10_4155_fmc_2017_0215 crossref_primary_10_1039_D0SC04750C crossref_primary_10_1007_s00330_023_09423_4 crossref_primary_10_1039_C8CC08875F crossref_primary_10_1039_D0TB00721H crossref_primary_10_1039_D0CC04372A crossref_primary_10_1002_jbio_202100149 crossref_primary_10_1016_j_jconrel_2021_05_029 crossref_primary_10_1021_acsbiomaterials_0c01076 crossref_primary_10_1016_j_bioactmat_2020_12_001 crossref_primary_10_1007_s10334_019_00738_2 crossref_primary_10_1016_j_cis_2020_102213 crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023045298 |
Cites_doi | 10.1016/S0169-409X(98)00099-4 10.1016/j.jvs.2007.01.023 10.1038/nbt920 10.1148/radiol.2203010090 10.1002/cncr.11464 10.3748/wjg.v21.i19.5831 10.1089/lrb.2008.1008 10.1002/jmri.1880070111 10.1016/j.ejrad.2005.12.044 10.2463/mrms.11.99 10.1148/radiology.218.3.r01fe21664 10.1148/radiol.2302021380 10.1097/00004728-200307000-00036 10.1016/j.jconrel.2009.01.010 10.1097/01.rli.0000065423.05038.88 10.1186/s12885-015-1255-4 10.1016/j.jconrel.2010.08.018 10.1016/j.mri.2009.10.005 10.1002/jmri.22422 10.1097/00004424-200302000-00002 |
ContentType | Journal Article |
Copyright | 2017 International Society for Magnetic Resonance in Medicine 2017 International Society for Magnetic Resonance in Medicine. 2018 International Society for Magnetic Resonance in Medicine |
Copyright_xml | – notice: 2017 International Society for Magnetic Resonance in Medicine – notice: 2017 International Society for Magnetic Resonance in Medicine. – notice: 2018 International Society for Magnetic Resonance in Medicine |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TK 8FD FR3 K9. P64 7X8 |
DOI | 10.1002/jmri.25740 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-2586 |
EndPage | 245 |
ExternalDocumentID | 10_1002_jmri_25740 28419613 JMRI25740 |
Genre | article Journal Article |
GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TK 8FD FR3 K9. P64 7X8 |
ID | FETCH-LOGICAL-c4590-b05ea1d28e1880a1997f44f94996c48de9c45839733561d354153aaf423c08f63 |
IEDL.DBID | DR2 |
ISSN | 1053-1807 |
IngestDate | Fri Aug 16 03:01:14 EDT 2024 Thu Oct 10 22:59:29 EDT 2024 Fri Aug 23 02:04:56 EDT 2024 Sat Sep 28 08:38:46 EDT 2024 Sat Aug 24 00:59:48 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | inflammation MR lymphography contrast agent |
Language | English |
License | 2017 International Society for Magnetic Resonance in Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4590-b05ea1d28e1880a1997f44f94996c48de9c45839733561d354153aaf423c08f63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmri.25740 |
PMID | 28419613 |
PQID | 1975482327 |
PQPubID | 1006400 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1889779909 proquest_journals_1975482327 crossref_primary_10_1002_jmri_25740 pubmed_primary_28419613 wiley_primary_10_1002_jmri_25740_JMRI25740 |
PublicationCentury | 2000 |
PublicationDate | January 2018 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: January 2018 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Nashville |
PublicationSubtitle | JMRI |
PublicationTitle | Journal of magnetic resonance imaging |
PublicationTitleAlternate | J Magn Reson Imaging |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2004; 22 2001; 220 2015; 15 2004; 230 2010; 28 2010; 148 1986; 46 2006; 58 1999; 37 2015; 21 2011; 33 2007 2003; 38 2003; 27 2008; 6 2001; 218 2014; 9 2007; 45 2012; 11 2009; 136 2003; 98 1997; 7 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_21_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_22_1 e_1_2_5_4_1 e_1_2_5_3_1 Matsumura Y (e_1_2_5_23_1) 1986; 46 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 Nehoff H (e_1_2_5_24_1) 2014; 9 e_1_2_5_20_1 |
References_xml | – volume: 46 start-page: 6387 year: 1986 end-page: 6392 article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs publication-title: Cancer Res – start-page: 238 year: 2007 end-page: 239 – volume: 22 start-page: 93 year: 2004 end-page: 97 article-title: Near‐infrared fluorescent type II quantum dots for sentinel lymph node mapping publication-title: Nat Biotechnol – volume: 136 start-page: 14 year: 2009 end-page: 20 article-title: Preparation and in vivo imaging of PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agents publication-title: J Control Release – volume: 38 start-page: 358 year: 2003 end-page: 365 article-title: Sentinel node detection using contrast‐enhanced power Doppler ultrasound lymphography publication-title: Invest Radiol – volume: 230 start-page: 543 year: 2004 end-page: 552 article-title: Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience publication-title: Radiology – volume: 7 start-page: 75 year: 1997 end-page: 81 article-title: Iron oxide‐enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer publication-title: J Magn Reson Imaging – volume: 38 start-page: 73 year: 2003 end-page: 84 article-title: Visualization of breast lymphatic pathways with an indirect computed tomography lymphography using a nonionic monometric contrast medium iopamidol: preliminary results publication-title: Invest Radiol – volume: 220 start-page: 816 year: 2001 end-page: 821 article-title: Interstitial MR lymphography with gadoterate meglumine: initial experience in humans publication-title: Radiology – volume: 33 start-page: 490 year: 2011 end-page: 497 article-title: Interstitial MR lymphography in mice with gadopentetate dimeglumine and gadoxetate disodium publication-title: J Magn Reson Imaging – volume: 28 start-page: 273 year: 2010 end-page: 280 article-title: Diet and gastrointestinal signal on T1‐weighted magnetic resonance imaging of mice publication-title: Magn Reson Imaging – volume: 21 start-page: 5831 year: 2015 end-page: 5842 article-title: Magnetic resonance imaging of the pancreas in streptozotocin‐induced diabetic rats: Gadofluorine P and Gd‐DOTA publication-title: World J Gastroenterol – volume: 6 start-page: 109 year: 2008 end-page: 122 article-title: The lymphatic system in health and disease publication-title: Lymphat Res Biol – volume: 218 start-page: 664 year: 2001 end-page: 669 article-title: Interstitial MR lymphography with a conventional extracellular gadolinium‐based agent: assessment in rabbits publication-title: Radiology – volume: 9 start-page: 2539 year: 2014 end-page: 2555 article-title: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect publication-title: Int J Nanomed – volume: 37 start-page: 295 year: 1999 end-page: 312 article-title: Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography publication-title: Adv Drug Deliv Rev – volume: 45 start-page: 1016 year: 2007 end-page: 1021 article-title: Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema publication-title: J Vasc Surg – volume: 27 start-page: 641 year: 2003 end-page: 646 article-title: Interstitial magnetic resonance lymphography: comparative animal study of gadofluorine 8 and gadolinium diethylenetriamine‐pentaacetic acid publication-title: J Comput Assist Tomogr – volume: 11 start-page: 99 year: 2012 end-page: 107 article-title: Interstitial MR lymphography in mice: comparative study with gadofluorine 8, gadofluorine M, and gadofluorine P publication-title: Magn Reson Med Sci – volume: 148 start-page: 160 year: 2010 end-page: 167 article-title: Polyion complex micelle MRI contrast agents from poly(ethylene glycol)‐b‐poly(l‐lysine) block copolymers having Gd‐DOTA; preparations and their control of T(1)‐relaxivities and blood circulation characteristics publication-title: J Control Release – volume: 58 start-page: 375 year: 2006 end-page: 382 article-title: MR contrast agents in lymph node imaging publication-title: Eur J Radiol – volume: 15 start-page: 213 year: 2015 article-title: Sentinel lymph node detection using magnetic resonance lymphography with conventional gadolinium contrast agent in breast cancer: a preliminary clinical study publication-title: BMC Cancer – volume: 98 start-page: 413 year: 2003 end-page: 423 article-title: Insights into the mechanisms of lymph node metastasis publication-title: Cancer – ident: e_1_2_5_12_1 doi: 10.1016/S0169-409X(98)00099-4 – ident: e_1_2_5_7_1 doi: 10.1016/j.jvs.2007.01.023 – volume: 46 start-page: 6387 year: 1986 ident: e_1_2_5_23_1 article-title: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs publication-title: Cancer Res contributor: fullname: Matsumura Y – ident: e_1_2_5_6_1 doi: 10.1038/nbt920 – ident: e_1_2_5_11_1 doi: 10.1148/radiol.2203010090 – ident: e_1_2_5_2_1 doi: 10.1002/cncr.11464 – ident: e_1_2_5_21_1 doi: 10.3748/wjg.v21.i19.5831 – ident: e_1_2_5_3_1 doi: 10.1089/lrb.2008.1008 – ident: e_1_2_5_10_1 doi: 10.1002/jmri.1880070111 – ident: e_1_2_5_4_1 doi: 10.1016/j.ejrad.2005.12.044 – ident: e_1_2_5_16_1 doi: 10.2463/mrms.11.99 – ident: e_1_2_5_20_1 doi: 10.1148/radiology.218.3.r01fe21664 – ident: e_1_2_5_8_1 doi: 10.1148/radiol.2302021380 – ident: e_1_2_5_14_1 doi: 10.1097/00004728-200307000-00036 – ident: e_1_2_5_22_1 – ident: e_1_2_5_17_1 doi: 10.1016/j.jconrel.2009.01.010 – ident: e_1_2_5_5_1 doi: 10.1097/01.rli.0000065423.05038.88 – volume: 9 start-page: 2539 year: 2014 ident: e_1_2_5_24_1 article-title: Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect publication-title: Int J Nanomed contributor: fullname: Nehoff H – ident: e_1_2_5_13_1 doi: 10.1186/s12885-015-1255-4 – ident: e_1_2_5_18_1 doi: 10.1016/j.jconrel.2010.08.018 – ident: e_1_2_5_19_1 doi: 10.1016/j.mri.2009.10.005 – ident: e_1_2_5_15_1 doi: 10.1002/jmri.22422 – ident: e_1_2_5_9_1 doi: 10.1097/00004424-200302000-00002 |
SSID | ssj0009945 |
Score | 2.3607137 |
Snippet | Purpose
To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic... To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic resonance... Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic... PURPOSETo investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)-b-poly(L-lysine-DOTA) (Gd-micelle) as a contrast agent for magnetic... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 238 |
SubjectTerms | Animals Aorta Area Under Curve Biopsy contrast agent Contrast agents Contrast Media - chemistry Coordination Complexes - chemistry Factorial analysis Feasibility Studies Female Fluorocarbons - chemistry Freund's Adjuvant Gadolinium Gadolinium - chemistry Image Processing, Computer-Assisted Inflammation Lymph nodes Lymph Nodes - diagnostic imaging Lymphatic system Lymphography Lysine Magnetic Resonance Imaging Mice Mice, Inbred BALB C Micelles MR lymphography Polyethylene glycol Polyethylene Glycols - chemistry Polylysine - chemistry Qualitative analysis Sacrum Variance analysis |
Title | PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agent: Feasibility study of a Gd‐micelle contrast agent for MR lymphography |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.25740 https://www.ncbi.nlm.nih.gov/pubmed/28419613 https://www.proquest.com/docview/1975482327 https://search.proquest.com/docview/1889779909 |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPaBeeLQ8AgW5KgdAyjaJndhGXKo-qViEKir1giInsVXoNrvq7h7KiTuX_sb-ks44ya6WSkhws-TYjj0zns_2-DPAaxkJpw2XITojG4qSi9BYEYdFZKSrEie0orvD_c_Z4Yk4Ok1Pl-BDdxem4YeYbbiRZfj5mgzcFOOtOWnoj4vL7z1UOEEL9phLiufaPZ5zR2ntXyhG_MDDWEVyxk2abM2LLnqjOxBzEbF6l7P_AL51P9tEmpz3ppOiV_78g8fxf3vzEO63WJRtN8rzCJZsvQr3-u1p-xr8_rJ3cPPrejQcXL35hAliL6ntW0yR76sYZfgDH0Zv2g8GlvWPPzIf_G7GE2bo1tZ7hiCzDcG9Yp7Mlg0dM-ygwnq6cotlGAJprIph7aOzllL7MZzs733dOQzbxxvCUqQ6QmGn1sRVoiwxvhmKZ3EC9QJXWFkpVGV1SUe2WnKOEK7iKSIJboxDeFdGymX8CSzXw9o-A2aIwy6zSspMi6hIEeEQTaGLnE2MEVkAm50Q81HD0ZE3bMxJTuOa-3ENYL2Tb97a6TiPtcQlG6JKGcDGLBstjHpvajuc4jdKIUhGr60DeNroxawZdO44hcU8gHdeun9pPz9CGfjU83_5-AWsIEZTza7POixPLqf2JeKgSfHK6_sthOkGWg |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrVS4UMozfWEEB0DKNomd2OZW9bUtuxWqWqm3yJvYomXJrrq7h3LizoXfyC9hxsnuakFCgpul-CFnZjyf7fE3AK9lJJw2XIbojGwoCi5CY0Uc9iIjXZk4oRW9He6eZe1LcXqVXjWxOfQWpuaHmB24kWX49ZoMnA6kd-esoTdfbq9bqHECd-wraO-cMjccnM_Zo7T2OYoRQfAwVpGcsZMmu_O2i_7oD5C5iFm90zlaqzOrjjxXIcWafG5Nxr1W8fU3Jsf_ns9DeNDAUbZX6886LNnqEax2mwv3x_D94-Hxz28_hoP-3ZsOFojApLJvsUTur2T0wd_5MEpr3-9b1j0_YT7-3YzGzNDDrfcMcWYThXvHPJ8tGzhm2HGJ_UzbLbZhiKWxK4a9Dz81rNpP4PLo8GK_HTb5G8JCpDpCeafWxGWiLJG-GQppcQJVAzdZWSFUaXVBt7Zaco4oruQpgglujEOEV0TKZfwpLFeDyj4HZojGLrNKykyLqJciyCGmQhc5mxgjsgBeTaWYD2uajrwmZE5y-q-5_68BbE0FnDemOspjLXHXhsBSBvBy9hmNjGZvKjuYYB2lECej49YBPKsVYzYM-ndcxWIewDsv3r-Mn5-iDHxp418qv4B77YtuJ--cnH3YhPsI2VR9CLQFy-Pbid1GWDTu7Xjl_wXJiwpy |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hkBCXFvoMLNQVPdBKWZLYiW3EpWpZnosQKhIXFHkTWzyW7IrdPcCJOxd-Y39Jx06yq22lSu3NkmM79sx4PtvjzwCfeMCMVJT76Iy0zzLKfKVZ6HcCxU0eGSaFvTvcPk72ztjBeXw-A9v1XZiSH2K84WYtw83X1sD7udmckIZe395dNVHhGC7Y51iC0NdCotMJeZSU7oliBBDUD0XAx-Sk0eak7LQ7-gNjTkNW53NaL-Gi_tsy1OSmORp2mtnDb0SO_9udRXhRgVHytdSeJZjRxSuYb1fH7a_h6WRn9-fjc7_Xvd84woSlLyn0Z0xZ55cTm-FOfIh91L7b1aR9uk9c9LsaDImy17a2CKLMKgb3njg2W9IzRJHdHOupy02XIYiksSqCtfcvK07tN3DW2vnxbc-vXm_wMxbLAKUdaxXmkdCW8k3ZgBbDUDFwiZVkTORaZvbMVnJKEcPlNEYoQZUyiO-yQJiEvoXZolfo90CUJbFLtOA8kSzoxAhxLE-hCYyOlGKJB-u1ENN-SdKRlnTMUWrHNXXj6kGjlm9aGeogDSXHNRvCSu7Bx3E2mpjtvSp0b4TfCIEoGd229OBdqRfjZtC74xwWUg--OOn-pf30AGXgUsv_8vEHmD_53kqP9o8PV2AB8Zood4AaMDu8G-lVxETDzppT_V-vEgkh |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PEG-poly%28L-lysine%29-based+polymeric+micelle+MRI+contrast+agent%3A+Feasibility+study+of+a+Gd-micelle+contrast+agent+for+MR+lymphography&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Akai%2C+Hiroyuki&rft.au=Shiraishi%2C+Kouichi&rft.au=Yokoyama%2C+Masayuki&rft.au=Yasaka%2C+Koichiro&rft.date=2018-01-01&rft.eissn=1522-2586&rft.volume=47&rft.issue=1&rft.spage=238&rft_id=info:doi/10.1002%2Fjmri.25740&rft_id=info%3Apmid%2F28419613&rft.externalDocID=28419613 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |